Physical Therapists in Columbus, KS Accepting Medicare
2 Physical Therapists found. Showing 1 - 2
 Susan Jane Campbell, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 101 E Elm St, Columbus, KS 66725 Phone: 256-810-8290 |
 The Max Therapy Center, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 101 E Elm St, Columbus, KS 66725 Phone: 256-810-8290 |
News Archive
Microarrays acquired from Vanderbilt University
Microarrays, Inc. (MI), an innovator of array-based technologies for biological research, detection and diagnostics, today announced that the company's management team and a group of independent investors have purchased MI from Vanderbilt University. The new company structure will allow MI to more quickly and nimbly respond to client's rapidly expanding needs, especially within the diagnostic and health care arenas.
Quantum cascade detector paves way for compact, portable infrared-imaging technology
The primary source of infrared radiation is heat - the radiation produced by the thermal motion of charged particles in matter, including the motion of the atoms and molecules in an object.
Genetic interaction with diet causes variations in metabolic traits
Ever notice some people seem to eat anything they want and never gain a pound, while others seem to gain weight just by looking at fattening foods. You may be seeing things correctly after all. According to research published in the July 2010 issue of Genetics, this may have a biological cause. Using fruit flies, researchers have found that genes interacting with diet, rather than diet alone, are the main cause of variation in metabolic traits, such as body weight. This helps explain why some diets work better for some people than others, and suggests that future diets should be tailored to an individual's genes rather than to physical appearance.
Researchers explore how to optimally control diseases in prison population using rapid tests
The use of rapid tests to screen for diseases in prisons could enable the diagnosis of asymptomatic individuals and reduce the spread of infection. Victor Riquelme, Pedro Gajardo, and Diego Vicencio (all from the Universidad Técnica Federico Santa María in Chile) recently explored how to optimally control a communicable disease inside a prison population using inexpensive, low-complexity rapid tests that personnel can administer with only basic training.
Updated data from Allos Therapeutics' ongoing FOLOTYN study
Allos Therapeutics, Inc. today announced updated data from its ongoing dose finding Phase 1 study of FOLOTYN™ (pralatrexate injection) in patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). These data were showcased during an oral presentation at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, LA.
› Verified 7 days ago